Assetmark, Inc Roivant Sciences Ltd. Transaction History
Assetmark, Inc
- $41.6 Billion
- Q2 2025
A detailed history of Assetmark, Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Assetmark, Inc holds 247 shares of ROIV stock, worth $4,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247
Previous 170
45.29%
Holding current value
$4,907
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
361Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.19 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$888 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$781 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$703 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$680 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...